Mayne Pharma reported AUD4.99M in EBITDA for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Ansell ANN:AU USD 178.7M 32.4M
Cochlear COH:AU AUD 213M 45.8M
Ecofibre Ltd EOF:AU AUD -8074000 776K
Healius Ltd HLS:AU AUD 258.7M 249.5M
Integral Diagnostics Ltd IDX:AU AUD 36.81M 4.8M
Medical Developments International Ltd MVP:AU AUD -7372000 14.4M
Nanosonics Ltd NAN:AU AUD 1.3M 4.97M
Next Science Ltd NXS:AU USD -6240610 1.35M
Polynovo Ltd PNV:AU AUD -642440 3.17M
Probiotec Ltd PBP:AU AUD 12.91M 2.74M
Ramsay Health Care RHC:AU AUD 584M 189.1M
ResMed RMD:AU USD 326.37M 31.7M
Sigma Healthcare Ltd SIG:AU AUD 28.59M 5.82M
Sonic Healthcare SHL:AU AUD 1.29B 248.31M
Telix Pharmaceuticals Ltd TLX:AU AUD -66472000 22.18M